United Therapeutics (UTHR) Prepaid Assets (2009 - 2026)
United Therapeutics (UTHR) posted Prepaid Assets of $228.0 million for Q1 2026, down 8.4% sequentially from $248.9 million in Q4 2025, and up 73.91% YoY from $131.1 million in Q1 2025.
United Therapeutics (UTHR) Prepaid Assets (2009 - 2026) Analysis & Trends
United Therapeutics has reported Prepaid Assets for 18 years, with the latest figure at $228.0 million in Q1 2026.
- Quarterly Prepaid Assets rose 73.91% year-over-year to $228.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $228.0 million (up 73.91% YoY) and the FY2025 annual result came in at $248.9 million, up 46.67% from the prior year.
- Prepaid Assets fell to $228.0 million in Q1 2026 per UTHR's latest filing, from $248.9 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $252.2 million in Q3 2025 and troughed at $60.2 million in Q1 2022.
- A 5-year average of $175.3 million and a median of $169.7 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 118.33% in 2022, then retreated 24.18% in 2023.
- Over 5 years, Prepaid Assets stood at $219.2 million in 2022, then slipped by 24.18% to $166.2 million in 2023, then gained by 2.11% to $169.7 million in 2024, then jumped by 46.67% to $248.9 million in 2025, then declined by 8.4% to $228.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $228.0 million, $248.9 million, and $252.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 317.30 Mn |
| Mar 31, 2026 | 228.00 Mn |
| Dec 31, 2025 | 248.90 Mn |
| Sep 30, 2025 | 252.20 Mn |
| Jun 30, 2025 | 229.70 Mn |
| Mar 31, 2025 | 131.10 Mn |
| Dec 31, 2024 | 169.70 Mn |
| Sep 30, 2024 | 185.40 Mn |
| Jun 30, 2024 | 220.80 Mn |
| Mar 31, 2024 | 113.40 Mn |
| Dec 31, 2023 | 166.20 Mn |
| Sep 30, 2023 | 220.50 Mn |
| Jun 30, 2023 | 158.40 Mn |
| Mar 31, 2023 | 92.60 Mn |
| Dec 31, 2022 | 219.20 Mn |
| Sep 30, 2022 | 118.10 Mn |
| Jun 30, 2022 | 165.80 Mn |
| Mar 31, 2022 | 60.20 Mn |
| Dec 31, 2021 | 100.40 Mn |
| Sep 30, 2021 | 76.00 Mn |